India’s Supreme Court Approves $1.18bn Settlement in Sandesara Case

The Supreme Court of India has sanctioned a full and final settlement in the Sterling Biotech dispute led by industrialist Nitin J. Sandesara’s group. Under the deal, the consortium of banks recovered $422 million directly, with an additional $144 million realised through asset liquidations. A compliance order confirmed $616 million deposited by court directive, bringing total recoveries to about $1.18 billion. The court ordered all related proceedings, including those by the CBI, Enforcement Directorate and Serious Fraud Investigation Office, to be closed. It also directed the securities regulator to finalise outstanding regulatory steps within a week. This resolution stands among India’s largest corporate recoveries, reinforcing how structured settlements can resolve complex financial disputes to the benefit of lender banks and the government.

Use The App To Win ₦1m

Stories are shared by community members. This article does not represent the official view of NaijaWorld — the author is solely responsible for its content.